CervoMed Q1 EPS $(0.41) Misses $(0.39) Estimate, Sales $2.35M Beat $1.35M Estimate
Portfolio Pulse from Benzinga Newsdesk
CervoMed (NASDAQ:CRVO) reported Q1 earnings per share (EPS) of $(0.41), missing the analyst estimate of $(0.39) by 5.13%. However, the company saw a significant improvement from the $(1.95) per share loss in the same period last year. Quarterly sales were $2.35 million, surpassing the analyst estimate of $1.35 million by 73.85%.
May 15, 2024 | 12:14 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
CervoMed reported a Q1 EPS of $(0.41), missing estimates by 5.13%, but showed a significant improvement from last year's $(1.95) per share loss. Sales of $2.35 million beat expectations by 73.85%.
Despite missing EPS estimates, CervoMed showed a significant improvement in reducing losses compared to the same period last year. Additionally, the company exceeded sales expectations by a large margin, which is likely to have a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100